Advertisement

Strategies for Evaluation of Antiviral Agents Against Epstein-Barr Virus in Culture

  • Jung-Chung Lin
Part of the Methods in Molecular Medicine™ book series (MIMM, volume 24)

Abstract

Evaluation of antiviral agents against Epstein-Barr virus (EBV) has been hampered by the lack of a permissive cell system for the replication of this virus. The extent of EBV replication detected in producer cell lines (P3HR-1 and B95-8) is limited: only a small fraction (<10%) of the cell population spontaneously produces virus at any given time. Attempts to increase the virus yield by manipulation of the culture conditions, such as temperature shifts, exposure to halogenated pyrimidines, such as BUdR and IUdR, and X-ray, have not been very successful. Superinfection of Raji (a nonvirus-producer line) cells with P3HR-1 virus enhances EBV replication and provides a more efficient system for evaluation of antiviral drugs. However, this method requires infection with virus isolated from a large quantity of culture fluids of P3HR-1 cells The virus yield varies from preparation to preparation. In addition, the system is not practical for large-scale drug screening.

Keywords

Raji Cell Virus Yield Trypan Blue Exclusion Method Antigen Synthesis Benchtop Centrifuge 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    zur Hausen, H., O’Neill, F. J., and Freeze, J. K. (1978) Persisting oncogenic herpesvirus induced by the tumor promoter TPA. Nature (London) 272, 373–375.Google Scholar
  2. 2.
    Lin, J.C., Shaw, J. E., Smith, M. C., and Pagano, J. S. (1979) Effect of 12-O-tetradecanoyl-phorbol-13-acetate on the replication of Epstein-Barr virus. I. Characterization of viral DNA. Virology 99, 183–187.CrossRefPubMedGoogle Scholar
  3. 3.
    Lin, J. C., Smith, M. C., and Pagano, J. S. (1982) Effects of 12-O-tetra-decanoyl-phorbol-13-acetate on cell proliferation and Epstein-Barr virus DNA replication. Virology 117, 186–194.CrossRefPubMedGoogle Scholar
  4. 4.
    Lin, J. C., Smith, M. C., and Pagano, J. S. (1983) Activation of latent Epstein-Barr virus genomes: selective stimulation of synthesis of chromosomal proteins by a tumor promoter. J. Virol. 45, 985–991.PubMedGoogle Scholar
  5. 5.
    Mar, E. C. and Lin, J. C. (1996) Effects of temporal treatments of nucleoside analogs on replication of Epstein-Barr virus. Ninth International Conference on Antiviral Research, Fukushima, Japan, May 19–24.Google Scholar
  6. 6.
    Lin, J. C., Smith, M. C., and Pagano, J. S. (1984) Prolonged inhibitory effect of 9-(1,3)-dihydroxy-2-propoxymethyl)guanine against replication of Epstein-Barr virus. J. Virol. 50, 50–55.PubMedGoogle Scholar
  7. 7.
    Lin, J. C., Zhang, Z. X., Chao, T. C., Sim, I., and Pagano, J. S. (1989) Synergistic inhibition of Epstein-Barr virus transformation of B lymphocytes by a and r interferon and by 3′-azido-3′-deoxythymidine. J. Infect. Dis. 159, 248–254.PubMedGoogle Scholar
  8. 8.
    Reed, L. J. and Muench, H. (1938) A simple method of estimating fifty percent endpoints. Am. J. Hygiene 27, 493–497.Google Scholar
  9. 9.
    Nonoyama, M. and Pagano, J. S. (1971) Detection of Epstein-Barr viral genome in nonproductive cells. Nature (London) New Biol. 233, 103–106.Google Scholar
  10. 10.
    Burton, K. (1956) A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of DNA. Biochem. J. 62, 315–319.PubMedGoogle Scholar

Copyright information

© Humana Press Inc. 2000

Authors and Affiliations

  • Jung-Chung Lin
    • 1
  1. 1.Department of MicrobiologyTzu Chi College of MedicineHualienTaiwan

Personalised recommendations